|
CSA2 Human, liver cancer |
| |
|
|
|
|
|
|
|
|
|
Age |
Sex |
Organ |
Diagnosis |
TNM |
Stage |
Months* |
|
1 |
41 |
M |
liver |
HCC |
T3N0M0 |
ⅢA |
. |
|
2 |
52 |
M |
liver |
HCC |
T3N0M0 |
ⅢA |
. |
|
3 |
56 |
M |
liver |
HCC |
T3N0M0 |
ⅢA |
. |
|
4 |
37 |
M |
liver |
HCC |
T4NxM1 |
Ⅳ |
. |
|
5 |
32 |
M |
liver |
HCC |
T3N0M0 |
ⅢA |
. |
|
6 |
57 |
M |
liver |
HCC |
T3N0M0 |
ⅢA |
. |
|
7 |
65 |
M |
liver |
moderately differentiated HCC |
T2N0M0 |
Ⅱ |
. |
|
8 |
72 |
M |
liver |
well & poorly differentiated HCC |
T2N0M0 |
Ⅱ |
. |
|
9 |
58 |
F |
liver |
well differentiated HCC |
T2N0M0 |
Ⅱ |
. |
|
10 |
52 |
M |
liver |
well differentiated HCC |
T2N0M0 |
Ⅱ |
. |
|
11 |
40 |
M |
liver |
moderately differentiated HCC |
T2N0M0 |
Ⅱ |
. |
|
12 |
67 |
M |
liver |
moderately differentiated HCC |
T2N0M0 |
Ⅱ |
. |
|
13 |
20 |
M |
liver |
well differentiated HCC |
T4N0M0 |
ⅢB |
. |
|
14 |
48 |
M |
liver |
moderately differentiated HCC |
T2N0M0 |
Ⅱ |
. |
|
15 |
47 |
M |
liver |
HCC |
T1N0M0 |
Ⅰ |
. |
|
16 |
69 |
F |
liver |
moderately differentiated HCC |
T2N0M0 |
Ⅱ |
. |
|
17 |
63 |
F |
liver |
moderately differentiated HCC |
T2N0M0 |
Ⅱ |
. |
|
18 |
60 |
F |
liver |
poorly differentiated HCC |
T2N0M0 |
Ⅱ |
. |
|
19 |
66 |
F |
liver |
well differentiated HCC |
T2N0M0 |
Ⅱ |
. |
|
20 |
64 |
M |
liver |
poorly differentiated HCC |
T3N0M0 |
ⅢA |
. |
|
21 |
64 |
M |
liver |
moderately differentiated HCC |
T2N0M0 |
Ⅱ |
. |
|
22 |
51 |
M |
liver |
moderately differentiated HCC |
T4N0M0 |
ⅢB |
. |
|
23 |
65 |
F |
liver |
moderately differentiated HCC |
T2N0M0 |
Ⅱ |
. |
|
24 |
41 |
M |
liver |
moderately differentiated HCC |
T2N0M0 |
Ⅱ |
. |
|
25 |
57 |
F |
liver |
well differentiated HCC |
T2N0M0 |
Ⅱ |
. |
|
26 |
57 |
M |
liver |
moderately differentiated HCC |
T3N0M0 |
ⅢA |
. |
|
27 |
50 |
|